말 유전자 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Equine Genetics Market Summary

The global equine genetics market size was estimated at USD 377.2 million in 2025 and is projected to reach USD 686.6 million by 2033, growing at a CAGR of 7.9% from 2026 to 2033. The market is significantly growing, driven by rising adoption of genomic tools in performance horse breeding and selection, regulatory mandates for parentage verification across breed registries, declining sequencing costs, expanding direct-to-consumer testing access, and strategic consolidation accelerating technology access across the value chain.

Genomic testing has become a foundational component of performance horse management, particularly within racing and competitive equine sports. Breed registries, racing authorities, and private breeders are increasingly integrating whole-genome sequencing and SNP-based panels into standard breeding protocols, moving away from phenotype-only selection toward genotype-informed decision-making. The commercial availability of performance-oriented genetic panels has been a significant catalyst. For instance, Etalon Equine Genetics offers DNA-based assessments covering speed aptitude, surface preference, and injury susceptibility, allowing trainers and owners to make data-backed acquisition and breeding decisions. Similarly, Equinome Labs provides Thoroughbred-specific tests evaluating race distance suitability and performance potential, directly influencing breeding pair selection at the highest competitive levels.

Global Equine Genetics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global equine genetics market report based on type, application, distribution channel, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Genetic Disease Testing
• Genomic
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Sports/ Racing
• Recreation
• Other Activities
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Private
• Public
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. Distribution Channel
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
• 1.6. Market Formulation & Visualization
• 1.7. Data Validation & Publishing
• 1.8. Model Details
  • 1.8.1. Bottom up Model
  • 1.8.2. Top Down Model
  • 1.8.3. Global Market: CAGR Calculation
• 1.9. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Equine Genetics Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Adoption Of Genomic Tools In Performance Horse Breeding And Selection
    • 3.2.1.2. Regulatory Mandates For Parentage Verification Across Breed Registries
    • 3.2.1.3. Declining Sequencing Costs Expanding Direct-To-Consumer Testing Access
    • 3.2.1.4. Strategic Consolidation Accelerating Technology Access Across The Value Chain
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack Of Standardization Across Testing Protocols And Breed Registry Databases
    • 3.2.2.2. Ethical And Regulatory Barriers Surrounding Cloning And Gene Editing In Competitive Sports
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Equine Genetics Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis, by SWOT
• 3.4. Technology Trend Analysis
• 3.5. Pricing Analysis, 2025
• 3.6. Estimated Equine Population, by key species & key countries, 2025

Chapter 4. Equine Genetics Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Equine Genetics Market: Type Movement Analysis
• 4.3. Equine Genetics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Genetics Disease Testing
  • 4.4.1. Genetics Disease Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Genomic
  • 4.5.1. Genomic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Equine Genetics Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Equine Genetics Market: Type Movement Analysis
• 5.3. Equine Genetics Market Size & Trend Analysis, by type, 2021 to 2033 (USD Million)
• 5.4. Sports/ Racing
  • 5.4.1. Sports/ Racing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Recreation
  • 5.5.1. Recreation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Other Activities
  • 5.6.1. Other Activities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Equine Genetics Market: By Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Equine Genetics Market: By Distribution Channel Movement Analysis
• 6.3. Equine Genetics Market Size & Trend Analysis, by Distribution Channel 2021 to 2033 (USD Million)
  • 6.3.1. Private
    • 6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Public
    • 6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Equine Genetics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Equine Genetics Market Share, By Region, 2025 & 2033 (USD Million)
• 7.3. Regional Outlook
• 7.4. North America
  • 7.4.1. North America Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Australia Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. South Korea Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Thailand Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.6. Qatar
    • 7.8.6.1. Key Country Dynamics
    • 7.8.6.2. Competitive Scenario
    • 7.8.6.3. Regulatory Framework
    • 7.8.6.4. Qatar Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.7. Oman
    • 7.8.7.1. Key Country Dynamics
    • 7.8.7.2. Competitive Scenario
    • 7.8.7.3. Regulatory Framework
    • 7.8.7.4. Oman Equine Genetics Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Position Analysis/ Heat Map Analysis, 2025
• 8.3. Company Profiles
  • 8.3.1. EquiSeq Inc
    • 8.3.1.1. Participant's Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Animal Genetics, Inc.
    • 8.3.2.1. Participant's Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. DDC
    • 8.3.3.1. Participant's Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. AffinityDNA
    • 8.3.4.1. Participant's Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. EasyDNA
    • 8.3.5.1. Participant's Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Etalon Equine Genetics
    • 8.3.6.1. Participant's Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Equinome Labs
    • 8.3.7.1. Participant's Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. VHLGenetics
    • 8.3.8.1. Participant's Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Genomia s.r.o.
    • 8.3.9.1. Participant's Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. GeneTech
    • 8.3.10.1. Participant's Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Equigerminal
    • 8.3.11.1. Participant's Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Product Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Victory Genomics
    • 8.3.12.1. Participant's Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Product Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. ViaGen Pets (Colossal Biosciences)
    • 8.3.13.1. Participant's Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Product Benchmarking
    • 8.3.13.4. Strategic Initiatives
  • 8.3.14. Clonargen Biotech
    • 8.3.14.1. Participant's Overview
    • 8.3.14.2. Financial Performance
    • 8.3.14.3. Product Benchmarking
    • 8.3.14.4. Strategic Initiatives